{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:26:40Z","timestamp":1787729200172,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01AI162246"],"award-info":[{"award-number":["R01AI162246"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01AI176949"],"award-info":[{"award-number":["R01AI176949"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014537","name":"Centre for Food and Allergy Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jconrel.2025.114166","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T15:08:52Z","timestamp":1756134532000},"page":"114166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Ultra-long-acting injectable, biodegradable, and removable in-situ forming implant with cabotegravir for HIV prevention"],"prefix":"10.1016","volume":"386","author":[{"given":"Thy","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella C.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie L.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar Shankar","family":"Kumbhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"De la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb T.","family":"Kozuszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanditha Chundayil","family":"Kalathil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani S.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D.M.","family":"Kashuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Rahima","family":"Benhabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114166_bb0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12879-018-3463-4","article-title":"A systematic review of adherence to oral pre-exposure prophylaxis for HIV \u2013 How can we improve uptake and adherence?","volume":"18","author":"Sidebottom","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.114166_bb0010","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2105\/AJPH.2015.302816","article-title":"How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize \u201cTruvada Whores,\u201d","volume":"105","author":"Calabrese","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.jconrel.2025.114166_bb0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cisgender men and transgender women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114166_bb0020","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","article-title":"Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial","volume":"399","author":"Delany-Moretlwe","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114166_bb0025","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1016\/S2352-3018(23)00261-8","volume":"10","author":"Landovitz","year":"2023","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jconrel.2025.114166_bb0030","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/S2352-3018(20)30106-5","article-title":"Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial","volume":"7","author":"Landovitz","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jconrel.2025.114166_bb0035","author":"UNAIDS"},{"key":"10.1016\/j.jconrel.2025.114166_bb0040","author":"UNAIDS"},{"key":"10.1016\/j.jconrel.2025.114166_bb0045","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMp038194","article-title":"The discovery of HIV as the cause of AIDS","volume":"349","author":"Gallo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114166_bb0050","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S0140-6736(11)61136-7","article-title":"Antiretroviral prophylaxis: a defining moment in HIV control","volume":"378","author":"Karim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114166_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","article-title":"Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model","volume":"373","author":"Granich","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114166_bb0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/bmj.324.7331.232","article-title":"The impact of HIV and AIDS on Africa\u2019s economic development","volume":"324","author":"Dixon","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2025.114166_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114166_bb0070","first-page":"53","article-title":"Towards an understanding of risk behavior: an AIDS risk reduction model (ARRM)","volume":"17","author":"Catania","year":"1990","journal-title":"Health Educ. Behav."},{"key":"10.1016\/j.jconrel.2025.114166_bb0075","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(08)60886-7","article-title":"Behavioural strategies to reduce HIV transmission: how to make them work better","volume":"372","author":"Coates","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114166_bb0080","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114166_bb0085","author":"Hare"},{"key":"10.1016\/j.jconrel.2025.114166_bb0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Damme","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114166_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048478","article-title":"Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations","volume":"12","author":"Murchu","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jconrel.2025.114166_bb0100","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1909512","article-title":"Long-acting Cabotegravir and Rilpivirine after Oral induction for HIV-1 infection","volume":"382","author":"Orkin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114166_bb0105","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0140-6736(20)32666-0","article-title":"Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study","volume":"396","author":"Overton","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114166_bb0110","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1038\/s41467-019-12141-5","article-title":"Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery","volume":"10","author":"Benhabbour","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114166_bb0115","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41467-023-36330-5","article-title":"Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection","volume":"14","author":"Young","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114166_bb0120","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jconrel.2023.10.006","article-title":"Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancy","volume":"363","author":"Young","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114166_bb0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jconrel.2013.08.024","article-title":"PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release","volume":"172","author":"Parent","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114166_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2165\/11631930-000000000-00000","article-title":"Bioequivalence and X-ray visibility of a radiopaque Etonogestrel implant versus a non-radiopaque implant","volume":"32","author":"Schnabel","year":"2012","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jconrel.2025.114166_bb0135","series-title":"Radiopaque Polyurethanes Containing Barium Sulfate: A Survey on Thermal, Rheological, Physical, and Structural Properties, Polymers","first-page":"3086","volume":"16","author":"J\u00fanior","year":"2024"},{"key":"10.1016\/j.jconrel.2025.114166_bb0140","author":"D.J.D. A"},{"key":"10.1016\/j.jconrel.2025.114166_bb0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.biomaterials.2005.05.099","article-title":"Polyurethanes with radiopaque properties","volume":"27","author":"James","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114166_bb0150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jbm.b.33235","article-title":"Bioabsorbable bone fixation plates for X-ray imaging diagnosis by a radiopaque layer of barium sulfate and poly(lactic-co-glycolic acid)","volume":"103","author":"Choi","year":"2015","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"key":"10.1016\/j.jconrel.2025.114166_bb0155","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.biomaterials.2004.09.055","article-title":"Static and fatigue mechanical behavior of bone cement with elevated barium sulfate content for treatment of vertebral compression fractures","volume":"26","author":"Kurtz","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114166_bb0160","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jconrel.2024.09.045","article-title":"Implant dynamics, inner structure, and their impact on drug release of in situ forming implants uncovered through CT imaging","volume":"375","author":"Lin","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114166_bb0165","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1208\/s12249-013-9960-2","article-title":"Dissolution studies of poorly soluble drug Nanosuspensions in non-sink conditions","volume":"14","author":"Liu","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2025.114166_bb0170","first-page":"1188","article-title":"Effects of drug physicochemical properties on in-situ forming implant polymer degradation and drug release kinetics","volume":"14","author":"Joiner","year":"2022","journal-title":"Pharm"},{"key":"10.1016\/j.jconrel.2025.114166_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2016.10.009","article-title":"Macroporous acrylamide phantoms improve prediction of in vivo performance of in situ forming implants","volume":"243","author":"Hernandez","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114166_bb0180","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s10439-017-1926-1","article-title":"Increasing distribution of drugs released from in situ forming PLGA implants using therapeutic ultrasound","volume":"45","author":"Manaspon","year":"2017","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114166_bb0185","first-page":"1524","article-title":"A new rectal model for dosimetry applications","volume":"40","author":"Mardirossian","year":"1999","journal-title":"J. Nucl. Med.\u202f: Off. Publ., Soc. Nucl. Med."},{"key":"10.1016\/j.jconrel.2025.114166_bb0190","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jconrel.2020.12.024","article-title":"Design and testing of a Cabotegravir implant for HIV prevention","volume":"330","author":"Karunakaran","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114166_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biomaterials.2017.10.023","article-title":"Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles","volume":"151","author":"Zhou","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114166_bb0200","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41563-020-0674-z","article-title":"A year-long extended release nanoformulated cabotegravir prodrug","volume":"19","author":"Kulkarni","year":"2020","journal-title":"Nat. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:42:45Z","timestamp":1777192965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925007783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"alternative-id":["S0168365925007783"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114166","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultra-long-acting injectable, biodegradable, and removable in-situ forming implant with cabotegravir for HIV prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114166"}}